Fuse Science Inc (DROP)

[Long-vestor]

Think Kylele, makes an excellent point and the results prove it..

Insulin delivery requires 100%.. and until Cure can discover the ability to deliver an equal it's dead in the water..

In the mean time, Fuse is on an excellent path.. I've said this before too.. it's fairly obvious, Fuse is the cash cow that Cure needs to continue research. good for the bulls seems to be that Cure's expenses or R&D contractual requirements are limited, which also may allow Fuse the become financially independent..

So, while Fuse is pitching the possibilities for Cure's developments,, The mainstream launch products are selling well, and may provide the short term payback on its stock.

the main key,, primary subject is; making cash off of DROP.. long term ownership in a start-up,, is never a good idea. But finding and buying a bottom is the name of this game..

It won't be too much longer and the dilution will cease,, at least for the short term.. ;)

What's the pivot?